Anakinra Homecare Service
key details
| Value | £180,000 |
|---|---|
| Status | active |
| Category (CPV) | 33600000 |
| Region | North East |
| Deadline | 19 Jan 2022 |
| Contract start | 1 Jun 2022 |
| Contract end | 31 May 2025 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-937fb889-79d4-45a5-8ff2-e0a6bf6b1c7e |
description
Text to be corrected in the original notice:
Place of text to be modified: VI.3)
Instead of: Additional Information: To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=649364168
Read: Additional Information: To view this notice, please click here:
https://www.delta-esourcing.com/respond/7794X82AZ7
Contract for the provision of an Anakinra Homecare Service for a 3 year period with an option to extend for up to a further 2 years
documents
- https://www.contractsfinder.service.gov.uk/Notice/639aa4d7-2e71-4098-8957-0765aa789686 , tenderNotice
- https://www.delta-esourcing.com/delta/respondToList.html?noticeId=649364168 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 8 Dec 2021 | Contract notice (F02) | Earlier regulations | 030570-2021 |
| 8 Dec 2021 | Corrigendum (F14) | Earlier regulations | 030574-2021 |
| 8 Dec 2021 | Tender amendment (tenderAmendment) | · | 639aa4d7-2e71-4098-8957-0765aa789686-492498 |
more from The Newcastle upon Tyne Hospitals NHS Foundation Trust
- Cardiology Insourcing · 23 Jul 2026
- Cellular Pathology · 23 Jul 2026
- Systemic Anti Cancer Therapy · 23 Jul 2026
- Paediatric Diabetes Network Support · 23 Jul 2026
- Laboratory Services Freeman Hospital · 23 Jul 2026
- Lab Services RVI - SQCL · 23 Jul 2026
- Breast Screening · 30 Jun 2026
- Stem Cell and Immunotherapy Services · 19 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.